51. Leucocyte- and platelet-rich fibrin block for bone augmentation procedure: A proof-of-concept study
- Author
-
Nelson Pinto, Marc Quirynen, Simone Cortellini, Jeroen Van Dessel, Andy Temmerman, Reinhilde Jacobs, and Ana B. Castro
- Subjects
0301 basic medicine ,Male ,Cone beam computed tomography ,Proof of Concept Study ,Fibrin ,03 medical and health sciences ,0302 clinical medicine ,Platelet-Rich Fibrin ,Leukocytes ,Maxilla ,Medicine ,Humans ,Bone regeneration ,GLUE ,biology ,business.industry ,Biomaterial ,030206 dentistry ,Alveolar Ridge Augmentation ,Middle Aged ,Platelet-rich fibrin ,Resorption ,030104 developmental biology ,Treatment Outcome ,biology.protein ,Guided Tissue Regeneration, Periodontal ,Periodontics ,Female ,business ,Nuclear medicine - Abstract
Aim The objective of this proof-of-concept study was to investigate the effects of a new guided bone regeneration technique with a tissue engineering approach. Materials and methods This single cohort observational study evaluated the outcome of the leucocyte- and platelet-rich fibrin (L-PRF) Block for horizontal bone augmentation in the maxilla. The L-PRF Block is prepared by mixing a particulated biomaterial with chopped L-PRF membranes at a 50:50 ratio and adding liquid fibrinogen to glue all together. Horizontal augmentation was assessed linearly and volumetrically immediately after surgery and 5-8 months later by matching consecutive cone beam computed tomography (CBCTs). Results Ten patients (mean age of 50.7 years [±17.2]) representing 15 sites with horizontal alveolar deficiencies were included. Superimposition of pre-operative and posthealing CBCT scans showed an average linear horizontal bone gain of 4.6 mm (±2.3), 5.3 mm (±1.2) and 4.4 mm (±2.3), measured at 2, 6 and 10 mm from the alveolar crest, respectively. The volumetric gain was 1.05 cm3 (±0.7) on average. The resorption rate after 5-8 months was 15.6% (±6.7) on average. Conclusions L-PRF Block may be a suitable technique to augment deficient alveolar ridges.
- Published
- 2018